Correlation Engine 2.0
Clear Search sequence regions

  • azithromycin (4)
  • child (1)
  • children (1)
  • humans (1)
  • infant (2)
  • macrolides (2)
  • mothers (1)
  • nasopharynx (3)
  • Sizes of these terms reflect their relevance to your search.

    In a post hoc analysis of samples from an intrapartum azithromycin randomized clinical trial, we found that children whose mothers had been treated with the drug had higher prevalence of macrolide-resistance genes msr(A) and ermC at 28 days but not at 12 months. The 2 genes were positively associated in the nasopharynx. NCT1800942. © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America.


    Abdoulie Bojang, Sarah L Baines, Bully Camara, Romain Guerillot, Liam Donovan, Raquel Sánchez Marqués, Ousman Secka, Umberto D'Alessandro, Christian Bottomley, Benjamin P Howden, Anna Roca. Impact of Intrapartum Oral Azithromycin on the Acquired Macrolide Resistome of Infants' Nasopharynx: A Randomized Controlled Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020 Dec 15;71(12):3222-3225

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 32445474

    View Full Text